Lifestyle
- Regular physical activity
- Avoid smoking
- Moderate alcohol consumption
Menaquinone-7 · MK-7 · Vitamin K2
Vitamin K2 (MK-7) measures the concentration of menaquinone-7 in the blood, reflecting its availability for biological processes such as coagulation and calcium regulation.
Ranges may vary with age and health status. Established for healthy women of childbearing age.
Vitamin K2 (MK-7), also known as Menaquinone-7, is a fat-soluble vitamin that plays a crucial role in blood coagulation, bone health, and cardiovascular function. It is a subtype of Vitamin K2, distinct from Vitamin K1, and is primarily involved in the carboxylation of specific proteins that regulate calcium deposition in bones and blood vessels. Researchers have found that MK-7 supplementation can increase plasma levels significantly, suggesting its potential role in reducing vascular calcification. Clinically, MK-7 is important for its potential to slow the progression of coronary artery calcification, particularly in patients with symptomatic coronary artery disease. It is also linked to bone health by influencing osteocalcin, a protein that binds calcium in the bone matrix. In the context of athletic performance and biohacking, MK-7 is of interest for its role in maintaining bone density and cardiovascular health, which are critical for longevity and optimal physical performance. However, the effectiveness of MK-7 can be influenced by factors such as chronic kidney disease, which alters its metabolism and distribution. Researchers observed that in such conditions, MK-7 uptake is impaired, suggesting that supplementation may have reduced efficacy. Additionally, the reference ranges for MK-7 can vary based on age, sex, and specific health conditions, necessitating careful interpretation of test results.
Klinische Bedeutung
Elevated levels of MK-7 may indicate adequate vitamin K status, supporting bone and cardiovascular health. Reduced levels can suggest a deficiency, potentially leading to increased risk of osteoporosis and vascular calcification.
Rising values may indicate improved vitamin K status or excessive supplementation. Re-test in 6 months if elevated.
Falling values suggest potential deficiency or increased need. Consider dietary review.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on anticoagulants.
Vitamin K levels may vary; morning samples recommended for consistency.
Testing Frequency
Annually for general health assessment
Current research suggests that reference ranges for MK-7 in diverse populations, particularly in specific age groups and health conditions, remain inadequately defined. Researchers have not yet established optimal MK-7 targets for preventing cardiovascular calcification or the impact of confounding factors like chronic kidney disease on its metabolism. Additionally, clinical questions remain unanswered regarding the long-term effects of MK-7 supplementation on plaque stability in patients with coronary artery disease.
357
Total Citations
11
Human/RCT
2.9
Avg. Influence
2026
Latest
Researchers described three novel polyphosphate-accumulating cocci from activated sludge, revealing their classification in a new genus, Tetrasphaera. The study identified menaquinones, including MK-7, in these strains, contributing to the understanding of microbial diversity and potential applications in bioremediation.
This study investigated vitamin K metabolism in patients with chronic kidney disease (CKD). Researchers found that CKD patients had reduced uptake of menaquinone-7 (MK-7) into lipoproteins compared to healthy individuals, indicating potential challenges in vitamin K transport and metabolism in these patients. The findings suggest that MK-7 supplementation may have reduced efficacy in CKD.
This study characterized a novel bacterial strain that produces menaquinone MK-7 as a major component. Researchers used a polyphasic approach to describe the strain's biochemical and physiological properties, contributing to the taxonomy of Brachybacterium species.
Researchers optimized a method for extracting and quantifying vitamin K forms, including MK-7, from various food matrices. The study demonstrated the method's effectiveness in measuring vitamin K content, which is important for understanding dietary sources of this nutrient.
This study identified a novel bacterial strain that produces menaquinone-7 (MK-7). Researchers characterized the strain's properties and confirmed its classification within the genus Paenibacillus. The strain's unique features contribute to understanding microbial sources of MK-7.
Researchers found that COVID-19 patients had significantly lower levels of Vitamin K2 (MK-7) compared to healthy controls and non-COVID-19 pneumonia patients. Additionally, COVID-19 patients exhibited decreased levels of Vitamin K1 and increased levels of MK-4. The study suggests that the consumption of MK-7 may be influenced by inflammatory and oxidative stress factors associated with COVID-19.
Neofytou Ioannis Eleftherios, et al. · Nutrients · 2024
This study explored the role of vitamin K in regulating vascular calcification in patients with chronic kidney disease (CKD). Researchers observed a strong association between vitamin K levels and cardiovascular disease risk in CKD patients. The study highlights the potential of vitamin K supplementation, though results from clinical trials remain inconsistent.
Key findings
This systematic review examined the effects of dietary interventions on gut microbiota in individuals with type 2 diabetes mellitus (T2DM). Researchers found that supplementation with vitamin K2 (MK-7) may positively influence gut microbiota composition, suggesting potential benefits for managing T2DM through dietary adjustments.
This research focused on enhancing the production of menaquinone-7 (MK-7) in Bacillus subtilis through adaptive laboratory evolution. Researchers observed that the evolved strain significantly increased MK-7 production by 76% under static conditions compared to the original strain. The study suggests potential applications for MK-7 production in probiotic formulations.
This study aimed to establish reference ranges for vitamin K indicators, including menaquinone-7 (MK-7), in healthy women of childbearing age in China. Researchers found that the reference range for MK-7 in serum was 0.12-3.54 ng/mL, providing a baseline for assessing vitamin K nutritional status. Cut-off values for subclinical vitamin K deficiency were also determined.
4
Total Trials
381
Total Enrolled
S.LAB (SOLOWAYS)
40
2024
Change in Bone Mineral Density (BMD)
University Hospitals Cleveland Medical Center
151
2022
Change in high-sensitivity C-reactive protein (hs-CRP) as measured by blood test
Ain Shams University
40
2020
change in serum level of Uncarboxylated MGP
Hopital St. Georges, Ajaltoun
150
2018
Evolution of the Aortic Valve Hemodynamic measured by echography: Change in Gradients in (mm Hg)
Research publications about Vitamin K2 (MK-7) over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer